SDH-related pheochromocytoma and paraganglioma

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 24, Issue 3, 2010, Pages 415-424

  Kantorovich, Vitaly ^a   King, Kathryn S ^b   Pacak, Karel ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Adrenal; Familial pheochromocytoma and paragangioma; Malignant pheochromocytoma and paragangioma; Paragangia; Paraganglioma; Pheochromocytoma; Succinate dehydrogenase; Succinate dehydrogenase subunit 5; Succinate dehydrogenase subunit A; Succinate dehydrogenase subunit B; Succinate dehydrogenase subunit C; Succinate dehydrogenase subunit D

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXAZOSIN; METIROSINE; PHENOXYBENZAMINE; PRAZOSIN; PROPRANOLOL; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE 5; SUCCINATE DEHYDROGENASE B; SUCCINATE DEHYDROGENASE C; SUCCINATE DEHYDROGENASE D; UNCLASSIFIED DRUG; VINCRISTINE;

CARCINOGENESIS; CLINICAL FEATURE; DRUG MEGADOSE; GENE MUTATION; GENETICS; HUMAN; OXIDATIVE PHOSPHORYLATION; PARAGANGLIOMA; PHEOCHROMOCYTOMA; REVIEW;

ADRENAL GLAND NEOPLASMS; HUMANS; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SUCCINATE DEHYDROGENASE;

EID: 77956603542     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.04.001     Document Type: Review

References (63)

1. K. Pacak, G.P. Chrousos, C.A. Koch, J.W. Lenders, and G. Eisenhofer Pheochromocytoma: progress in diagnosis, therapy, and genetics A. Margioris, G.P. Chrousos, 1st ed. Adrenal disorders vol. 1 2001 Humana Press Totowa 479 523
2. N. van Duinen, D. Steenvoorden, and I.P. Kema Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas The Journal of Clinical Endocrinology and Metabolism 95 1 Jan 2010 209 214
3. H.P. Neumann, B. Bausch, and S.R. McWhinney Germ-line mutations in nonsyndromic pheochromocytoma The New England Journal of Medicine 346 19 May 9 2002 1459 1466
4. Z. Erlic, L. Rybicki, and M. Peczkowska Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients Clinical Cancer Research 15 20 Oct 15 2009 6378 6385
5. S. Niemann, and U. Muller Mutations in SDHC cause autosomal dominant paraganglioma, type 3 Nature Genetics 26 3 2000 268 270
6. C. Ladroue, R. Carcenac, and M. Leporrier PHD2 mutation and congenital erythrocytosis with paraganglioma The New England Journal of Medicine 359 25 Dec 18 2008 2685 2692
7. P.L. Dahia, K. Hao, and J. Rogus Novel pheochromocytoma susceptibility loci identified by integrative genomics Cancer Research 65 21 Nov 1 2005 9651 9658
8. F. Schiavi, C.C. Boedeker, and B. Bausch Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene The Journal of the American Medical Association 294 16 Oct 26 2005 2057 2063
9. A.J. Kroll, B. Alexander, F. Cochios, and L. Pechet Hereditary deficiencies of clotting factors Vii and X associated with carotid-body tumors The New England Journal of Medicine 270 Jan 2 1964 6 13
10. C. Eng, M. Kiuru, M.J. Fernandez, and L.A. Aaltonen A role for mitochondrial enzymes in inherited neoplasia and beyond Nature Reviews 3 3 Mar 2003 193 202
11. P. Pigny, and C. Cardot-Bauters Genetics of pheochromocytoma and paraganglioma: new developments Annales d'endocrinologie Dec 21, 2009
12. A.G. van der Mey, P.D. Maaswinkel-Mooy, C.J. Cornelisse, P.H. Schmidt, and J.J. van de Kamp Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory Lancet 2 8675 Dec 2, 1989 1291 1294
13. B.E. Baysal, R.E. Ferrell, and J.E. Willett-Brozick Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma Science (New York, NY) 287 5454 2000 848 851
14. D. Astuti, F. Latif, and A. Dallol Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma American Journal of Human Genetics 69 1 Jul 2001 49 54
15. H.X. Hao, O. Khalimonchuk, and M. Schraders SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma Science (New York, NY) 325 5944 Aug 28, 2009 1139 1142
16. V. Yankovskaya, R. Horsefield, and S. Tornroth Architecture of succinate dehydrogenase and reactive oxygen species generation Science (New York, NY) 299 5607 Jan 31 2003 700 704
17. H.H. Dahl Getting to the nucleus of mitochondrial disorders: identification of respiratory chain-enzyme genes causing Leigh syndrome American Journal of Human Genetics 63 6 Dec 1998 1594 1597
18. Y. Qin, K. Buddavarapu, and P.L. Dahia Pheochromocytomas: from genetic diversity to new paradigms Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 41 9 Sep 2009 664 671
19. S. Schlisio, R.S. Kenchappa, and L.C. Vredeveld The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor Genes & Development 22 7 Apr 1, 2008 884 893
20. A.P. Gimenez-Roqueplo, J. Favier, and P. Rustin The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway American Journal of Human Genetics 69 6 Dec 2001 1186 1197
21. A.P. Gimenez-Roqueplo, J. Favier, and P. Rustin Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma The Journal of Clinical Endocrinology and Metabolism 87 10 Oct 2002 4771 4774
22. P.J. Pollard, J.J. Briere, and N.A. Alam Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations Human Molecular Genetics 14 15 Aug 1 2005 2231 2239
23. M.A. Selak, S.M. Armour, and E.D. MacKenzie Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase Cancer Cell 7 1 Jan 2005 77 85
24. J.P. Bayley, and P. Devilee Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree? Current Opinion in Genetics & Development Mar 19, 2010
25. F.H. van Nederveen, J. Gaal, and J. Favier An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis The Lancet Oncology 10 8 Aug 2009 764 771
26. J. Favier, J.J. Briere, and N. Burnichon The warburg effect is genetically determined in inherited pheochromocytomas PloS One 4 9 2009 e7094
27. H.P. Neumann, C. Pawlu, and M. Peczkowska Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations The Journal of the American Medical Association 292 8 Aug 25, 2004 943 951
28. L. Amar, J. Bertherat, and E. Baudin Genetic testing in pheochromocytoma or functional paraganglioma Journal of Clinical Oncology 23 34 Dec 1, 2005 8812 8818
29. D.E. Benn, A.L. Richardson, D.J. Marsh, and B.G. Robinson Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes Annals of the New York Academy of Sciences 1073 Aug 2006 104 111
30. N. Burnichon, V. Rohmer, and L. Amar The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas The Journal of Clinical Endocrinology and Metabolism 94 8 Aug 2009 2817 2827
31. F.H. Van Nederveen, W.N. Dinjens, E. Korpershoek, and R.R. De Krijger The occurrence of SDHB gene mutations in pheochromocytoma Annals of the New York Academy of Sciences 1073 Aug 2006 177 182
32. H.K. Ghayee, B. Havekes, and E.P. Corssmit Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior Endocrine-Related Cancer 16 1 Mar 2009 291 299
33. F.M. Brouwers, G. Eisenhofer, and J.J. Tao High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing The Journal of Clinical Endocrinology and Metabolism 91 11 Nov 2006 4505 4509
34. D.E. Benn, A.P. Gimenez-Roqueplo, and J.R. Reilly Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes The Journal of Clinical Endocrinology and Metabolism 91 3 Mar 2006 827 836
35. H.J. Timmers, A. Kozupa, and G. Eisenhofer Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas The Journal of Clinical Endocrinology and Metabolism 92 3 Mar 2007 779 786
36. B. Havekes, E.P. Corssmit, J.C. Jansen, A.G. van der Mey, A.H. Vriends, and J.A. Romijn Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene The Journal of Clinical Endocrinology and Metabolism 92 4 Apr 2007 1245 1248
37. T.H. Pham, C. Moir, and G.B. Thompson Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center Pediatrics 118 3 Sep 2006 1109 1117
38. T. Prodanov, B. Havekes, K.L. Nathanson, K.T. Adams, and K. Pacak Malignant paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old child: the age of first screening? Pediatric Nephrology Feb 3, 2009
39. H. Timmers, A.P. Gimenez-Roqueplo, M. Mannelli, and K. Pacak Clinical aspects of SDHx-related pheochromocytoma and paraganglioma Endocrine-Related Cancer Feb 3, 2009
40. H.J. Timmers, K. Pacak, and J. Bertherat Mutations associated with succinate dehydrogenase d-related malignant paragangliomas Clinical Endocrinology Oct 31, 2007
41. H.J. Timmers, K. Pacak, and J. Bertherat Mutations associated with succinate dehydrogenase D-related malignant paragangliomas Clinical Endocrinology 68 4 Apr 2008 561 566
42. K. Astrom, J.E. Cohen, J.E. Willett-Brozick, C.E. Aston, and B.E. Baysal Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect Human Genetics 113 3 Aug 2003 228 237
43. M. Mannelli, T. Ercolino, V. Giache, L. Simi, C. Cirami, and G. Parenti Genetic screening for pheochromocytoma: should SDHC gene analysis be included? Journal of Medical Genetics 44 9 Sep 2007 586 587
44. M. Peczkowska, A. Cascon, and A. Prejbisz Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation Nature Clinical Practice Endocrinology & Metabolism 4 2 Feb 2008 111 115
45. S. Niemann, U. Muller, D. Engelhardt, and P. Lohse Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC Human Genetics 113 1 Jul 2003 92 94
46. F. van Baars, C. Cremers, P. van den Broek, S. Geerts, and J. Veldman Genetic aspects of nonchromaffin paraganglioma Human Genetics 60 4 1982 305 309
47. J.P. Bayley, H.P. Kunst, and A. Cascon SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma The Lancet Oncology 11 4 Apr 2010 366 372
48. L. Yao, M. Barontini, B. Niederle, M. Jech, R. Pfragner, and P.L. Dahia Mutations of the metabolic genes IDH1, IDH2, and SDHAF2 are not major determinants of the pseudohypoxic phenotype of sporadic pheochromocytomas and paragangliomas The Journal of Clinical Endocrinology and Metabolism 95 3 2010 1469 1472
49. G. Eisenhofer, J.W. Lenders, and D.S. Goldstein Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines Clinical Chemistry 51 Feb 17, 2005 735 744
50. G. Eisenhofer, D.S. Goldstein, and P. Sullivan Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine The Journal of Clinical Endocrinology and Metabolism 90 Jan 11, 2005 2068 2075
51. H.J. Timmers, K. Pacak, and T.T. Huynh Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene The Journal of Clinical Endocrinology and Metabolism 93 12 Dec 2008 4826 4832
52. K. Pacak, G. Eisenhofer, and H. Ahlman Pheochromocytoma: recommendations for clinical practice from the First International Symposium Nature Clinical Practice Endocrinology & Metabolism 3 2 Feb 2007 92 102
53. A. Grossman, K. Pacak, and A. Sawka Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Annals of the New York Academy of Sciences 1073 Aug 2006 332 347
54. S. Maurea, A. Cuocolo, J.C. Reynolds, R.D. Neumann, and M. Salvatore Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison Quarterly Journal of Nuclear Medicine 40 4 1996 365 371
55. U. Niemann, W. Hiller, and M. Behrend 25 years experience of the surgical treatment of phaeochromocytoma European Journal of Surgery 168 12 2002 716 719
56. G. Stenstrom, I. Ernest, and L.E. Tisell Long-term results in 64 patients operated upon for pheochromocytoma Acta Medica Scandinavica 223 4 1988 345 352
57. A. Khorram-Manesh, H. Ahlman, and O. Nilsson Long-term outcome of a large series of patients surgically treated for pheochromocytoma Journal of Internal Medicine 258 1 Jul 2005 55 66
58. S.D. Averbuch, C.S. Steakley, and R.C. Young Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine Annals of Internal Medicine 109 4 1988 267 273
59. P.A. Fitzgerald, R.E. Goldsby, and J.P. Huberty Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG) Annals of the New York Academy of Sciences 1073 Aug 2006 465 490
60. S. Gonias, R. Goldsby, and K.K. Matthay Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma Journal of Clinical Oncology 27 25 Sep 1, 2009 4162 4168
61. R.E. Coleman, J.B. Stubbs, J.A. Barrett, M. de la Guardia, N. Lafrance, and J.W. Babich Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid Cancer Biotherapy & Radiopharmaceuticals 24 4 Aug 2009 469 475
62. G. Eisenhofer, S.R. Bornstein, and F.M. Brouwers Malignant pheochromocytoma: current status and initiatives for future progress Endocrine-Related Cancer 11 3 Sep 2004 423 436
63. A.L. Young, B.E. Baysal, A. Deb, and W.F. Young Jr. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene The Journal of Clinical Endocrinology & Metabolism 87 9 Sep 2002 4101 4105